Edgewise Therapeutics Inc.
Organization details
- Legal name
- Edgewise Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boulder
- Headquarters state / province
- Colorado
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- EWTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001710072
- EIN
- 82-1725586
Board of directors
-
Alan J. Russell · Director · Chief Scientific OfficerSince 2023
-
Arlene Morris · DirectorSince 2024
-
Badreddin Edris · DirectorSince 2023
-
Christopher Nathan Martin · DirectorSince 2025
-
Jonathan C. Fox · DirectorSince 2023
-
Jonathan D. Root · DirectorSince 2023
-
Kevin Koch · Director · President and CEOSince 2023
-
Laura Brege · DirectorSince 2023
- Since 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
65.0%
-
70.3%
-
95.8%
Board connections
5 of this board's directors also sit on 14 other boards. 14 are in the same sector.
-
ACADIA Pharmaceuticals Inc. Same sectorvia Laura Brege
-
ARS Pharmaceuticals Inc. Same sectorvia Peter A. Thompson
-
Achieve Life Sciences Inc. Same sectorvia Christopher Nathan Martin
-
Aspen Neuroscience Inc. Same sectorvia Peter A. Thompson
-
Carlsmed Inc. Same sectorvia Jonathan D. Root
-
Cogent Biosciences Inc. Same sectorvia Arlene Morris
-
Corvus Pharmaceuticals Inc. Same sectorvia Peter A. Thompson
-
Mirum Pharmaceuticals Inc. Same sectorvia Laura Brege
-
Omada Health Inc. Same sectorvia Jonathan D. Root
-
Oruka Therapeutics Inc. Same sectorvia Christopher Nathan Martin
-
Pacira BioSciences Inc. Same sectorvia Laura Brege
-
Palatin Technologies Inc. Same sectorvia Arlene Morris
-
Sionna Therapeutics Inc. Same sectorvia Peter A. Thompson
-
Viridian Therapeutics Inc. Same sectorvia Arlene Morris
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $19,704,688
- 34 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Nofi Michael Officer (Chief Financial Officer) | Option exercise | +10,937 | — | — |
| Nov 10, 2026 | Nofi Michael Officer (Chief Financial Officer) | Open-market sale | −4,442 | $45.43 | $201,787 |
| Oct 1, 2026 | Jonathan C. Fox Director | Grant or award | +308 | — | — |
| Aug 13, 2026 | Donovan Joanne M. Officer (CMO) | Open-market sale | −2,919 | $43.41 | $126,714 |
| Aug 12, 2026 | Derakhshan Behrad Officer (Chief Business Officer) | Option exercise | +5,781 | — | — |
| Aug 12, 2026 | Donovan Joanne M. Officer (CMO) | Option exercise | +5,781 | — | — |
| Aug 12, 2026 | Kevin Koch Director, Officer (President and CEO) | Option exercise | +17,969 | — | — |
| Aug 12, 2026 | MOORE JOHN R Officer (General Counsel) | Option exercise | +5,781 | — | — |
| Aug 12, 2026 | Alan J. Russell Director, Officer (Chief Scientific Officer) | Option exercise | +5,781 | — | — |
| Aug 12, 2026 | Derakhshan Behrad Officer (Chief Business Officer) | Option exercise | +7,500 | — | — |
| Aug 12, 2026 | Donovan Joanne M. Officer (CMO) | Option exercise | +7,031 | — | — |
| Aug 12, 2026 | Kevin Koch Director, Officer (President and CEO) | Option exercise | +21,875 | — | — |
| Aug 12, 2026 | MOORE JOHN R Officer (General Counsel) | Option exercise | +6,718 | — | — |
| Aug 12, 2026 | Alan J. Russell Director, Officer (Chief Scientific Officer) | Option exercise | +7,031 | — | — |
| Aug 12, 2026 | Derakhshan Behrad Officer (Chief Business Officer) | Open-market sale | −2,171 | $43.79 | $95,068 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Edgewise Therapeutics Inc.
Who is the CEO of Edgewise Therapeutics Inc.?
Kevin Koch is Edgewise Therapeutics Inc.'s President and CEO.
How many directors are on Edgewise Therapeutics Inc.'s board?
Edgewise Therapeutics Inc.'s board has 9 directors: Alan J. Russell, Arlene Morris, Badreddin Edris, Christopher Nathan Martin, Jonathan C. Fox, Jonathan D. Root, Kevin Koch, Laura Brege and Peter A. Thompson.
Are Edgewise Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Edgewise Therapeutics Inc. insiders made no open-market purchases and sold $19.7 million of shares in 34 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="edgewise-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.